Canker Care Plus

Description

Quantum® HEALTH Canker Care® Oral Gel is a pain reliever formulated to provide immediate pain relief for oral discomfort. This soothing protective gel is designed for application with a gentle brush applicator, ensuring precise delivery to affected areas. The product contains a blend of 15 nutrients, including lysine, licorice, aloe vera, propolis, and tea tree oil, contributing to its therapeutic properties. It is presented in a 0.33 fluid ounce (9.4 mL) container and features a fresh natural taste.

Uses and Indications

This drug is indicated for the temporary relief of mouth pain associated with canker sores, toothache, dentures, braces, or cheek bites.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be applied to the affected area up to four times daily, or as directed by a healthcare professional. It is important to follow the specific instructions provided by the prescribing physician or dentist to ensure optimal therapeutic outcomes.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

The product should not be used for more than 7 days unless specifically directed by a healthcare professional. Prolonged use beyond this period may lead to adverse effects or complications.

Healthcare professionals should advise patients to seek medical attention if symptoms of a sore mouth do not improve within 7 days. Additionally, patients should be instructed to consult their doctor or dentist if they experience worsening irritation, pain, or redness, or if they develop swelling, rash, or fever.

It is imperative that patients do not exceed the recommended dosage, as this may increase the risk of side effects. Furthermore, contact with the eyes must be strictly avoided to prevent irritation or injury.

To ensure safety, this product, along with all medications, should be kept out of the reach of children to prevent accidental ingestion or misuse.

Side Effects

Patients should be aware of the following warnings associated with the use of this product. It is advised not to use this product for more than 7 days unless directed by a health professional. If symptoms of a sore mouth do not improve within 7 days, or if irritation, pain, or redness worsens, or if any swelling, rash, or fever develops, patients should seek medical attention from a doctor or dentist.

Additionally, it is crucial for patients to adhere to the recommended dosage and to avoid contact with the eyes to prevent potential adverse effects.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Canker Care Plus (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this and all medications out of the reach of children. This precaution is essential to prevent accidental ingestion and potential harm.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be aware that no specific information regarding the use of this product during pregnancy is provided in the prescribing information. There are no statements indicating whether the product is contraindicated in pregnancy or any associated risks to the fetus. Additionally, no dosage modifications or special precautions regarding the use of this product during pregnancy are mentioned. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

Exceeding the recommended dosage of the medication can lead to serious health consequences. Healthcare professionals are advised to monitor patients closely for any signs of overdosage and to educate patients on the importance of adhering to prescribed dosages.

In the event of suspected overdosage, it is crucial to assess the patient for potential symptoms, which may vary depending on the specific medication involved. Common symptoms associated with overdosage may include, but are not limited to, gastrointestinal disturbances, central nervous system effects, and cardiovascular irregularities.

Management of overdosage should be initiated promptly. Healthcare providers should consider the following steps:

1. Immediate Assessment: Conduct a thorough evaluation of the patient's clinical status, including vital signs and level of consciousness.

2. Supportive Care: Provide supportive care as necessary, which may include intravenous fluids, monitoring of vital signs, and symptomatic treatment.

3. Decontamination: If the overdosage is recent, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Consultation: In cases of severe overdosage or when symptoms are significant, consultation with a poison control center or a medical toxicologist is recommended for further management guidance.

5. Documentation: Document all findings, interventions, and patient responses thoroughly in the medical record.

It is imperative that healthcare professionals remain vigilant and proactive in preventing overdosage by ensuring that patients understand their medication regimen and the importance of adhering to prescribed dosages.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of the reach of children. It is essential to emphasize the importance of proper storage to prevent accidental ingestion or misuse. Patients should be informed about the potential risks associated with leaving medications accessible to children and encouraged to take necessary precautions to ensure safety.

Storage and Handling

The product is supplied in a secure container, and it is essential to ensure that the shrink wrap seal covering the bottle and cap remains intact. If the seal is broken or missing, the product should not be used.

For optimal storage, the product should be kept in a controlled environment, away from direct sunlight and moisture. Specific temperature ranges for storage are not provided; however, it is advisable to maintain standard room temperature conditions to preserve product integrity.

Healthcare professionals are reminded to handle the product with care, adhering to the guidelines for safe storage and usage to ensure patient safety and product efficacy.

Additional Clinical Information

The medication is administered topically, with application to the affected area permitted up to four times a day, or as directed by a healthcare professional. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Canker Care Plus, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)